Idiopathic pulmonary fibrosis trials in Austria
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Linz, Salzburg, Vienna, Wels
- Age
- 40 years and over
- People
- 324 worldwide
- Run by
- Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00 - Phase 3Not yet taking people in AustriaLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Linz, Salzburg, Vienna
- Age
- 18 years and over
- People
- 2,380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
- Where
- Linz, Salzburg, Vienna
- Age
- 18 years and over
- People
- 239 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01 - Phase 3Taking peopleA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
- Where
- Linz, Salzburg, Vienna
- Age
- 18 years and over
- People
- 249 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00 - No phaseTaking peoplePRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- Where
- Graz
- Age
- 18 years to 80 years
- People
- 500 worldwide
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT06855329